W. Wilhelm et al., REMIFENTANIL WITH PROPOFOL OR ISOFLURANE - A COMPARISON OF RECOVERY TIMES AFTER ARTHROSCOPIC SURGERY, Anasthesist, 46(4), 1997, pp. 335-338
Objectives: Due to its unique pharmacokinetics, the new esterase-metab
olised opioid remifentanil results in rapid post-anaesthesia recovery.
The aim of this clinical investigation was to compare recovery times
after remifentanil anaesthesia in combination with hypnotic concentrat
ions of either propofol or isoflurane. Dosages used in the study proto
col were based on recommendations by the pharmaceutical manufacturer.
Methods: Patients (ASA status I-II) scheduled for elective arthroscopy
were included in this trial. Without premedication in the morning, an
aesthesia was induced identically in both groups: remifentanil bolus (
1 mu g/kg), start of remifentanil-infusion (0.5 mu g/kg/min), followed
immediately by propofol (ca.2 mg/kg). For maintenance of anaesthesia
remifentanil (0.25 mu g/kg/min) was combined with either a propofol in
fusion of 0.1 mg/kg/min or 0.5 MAC isoflurane (=0.6 vol.%) in O-2/air.
Anaesthetic delivery was discontinued simultaneously with termination
of surgery and recovery times were recorded. Results: A total of 40 p
atients were studied at random in two groups of 20 each with comparabl
e demographic data and anaesthetic technique (Tables 1 and 2). In both
groups emergence was very rapid. Recovery times were significantly sh
orter for remifentanil-isoflurane than for remifentanil-propofol (Tabl
e 3): spontaneous ventilation 5.1 vs 8.1 min (P<0.05), extubation 5.5
vs. 8.6 min (P<0.02), post-anaesthesia recovery score greater than or
equal to 9 of 10 points 6.2 vs 11.3 min (P<0.01), and arrival at PACU
16.2 vs 19.2 min (P<0.01). Mild to moderate shivering was noted in 40%
of all patients (9 cases following isoflurane, 7 following propofol).
Conclusions: Using the manufacturer's recommended dosages, emergence
after remifentanil anaesthesia is more rapid with 0.5 MAC isoflurane t
han with 0.1 mg/kg/min propofol. These results are most probably due t
o the different pharmacological properties of both co-anaesthetics, es
pecially the applied dosages, and to different interactions with remif
entanil. Present clinical experience suggests that a further dose redu
ction, especially for propofol, is possible. For both remifentanil gro
ups emergence was remarkably rapid between return of consciousness and
the awake state (on-off phenomenon), which might contribute to post a
naesthesia safety.